Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vaxxinity
Biotech
Vaxxinity retreats from 'abusive relationship' of public market
Vaxxinity is choosing transparency about the “abusive relationship” that defined the immunotherapy company’s three-year stint as a public company.
Annalee Armstrong
May 15, 2024 9:59am
Vaxxinity, UCF in collaboration to advance space medicine
Jan 18, 2024 8:47am
Vaxxinity seeks a partner to press ahead with Alzheimer's med
Mar 27, 2023 10:53am
Texas biotech’s COVID booster takes on competitors in phase 3
Dec 2, 2022 11:00am
